Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis clinical trials

Explore recruiting metabolic dysfunction associated steatohepatitis mash with compensated cirrhosis clinical trials.

Recruiting metabolic dysfunction associated steatohepatitis mash with compensated cirrhosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Spain, Hungary, Netherlands, Belgium, Bulgaria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis trials by city

Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Toronto Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Vancouver Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Montreal Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Calgary Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Edmonton Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Ottawa Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Winnipeg Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Quebec City Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Hamilton Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Kitchener Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in London Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Halifax Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in New York Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Los Angeles Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Chicago Metabolic Dysfunction Associated Steatohepatitis Mash With Compensated Cirrhosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease